Fax: (713) 792-2031
Therapy for elderly patients with acute myeloid leukemia†
A problem in search of solutions
Article first published online: 5 FEB 2007
Copyright © 2007 American Cancer Society
Volume 109, Issue 6, pages 1007–1010, 15 March 2007
How to Cite
Kantarjian, H. M. (2007), Therapy for elderly patients with acute myeloid leukemia. Cancer, 109: 1007–1010. doi: 10.1002/cncr.22502
See referenced Original Article on pages 000-000, this issue.
- Issue published online: 7 MAR 2007
- Article first published online: 5 FEB 2007
- Manuscript Accepted: 29 NOV 2006
- Manuscript Revised: 14 NOV 2006
- Manuscript Received: 1 NOV 2006
Elderly patients with acute myeloid leukemia (AML) have poor outcomes with standard intensive chemotherapy and are managed with supportive care, low-dose chemotherapy, or hospice care. In this Editorial, the topic is reviewed, and the author discusses the article in this issue of Cancer by Burnett et al concerning the use of low-dose cytarabine versus hydroxyurea in patients with AML who are considered unfit to receive intensive chemotherapy.